Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lytix Biopharma | 6BG | Nov 26, 2024 | 0.52 | -6.86 |
L`Oreal | LORA | Nov 26, 2024 | 67.00 | +1.52 |
M Vest Water | 7YA | Nov 26, 2024 | 0.81 | -4.71 |
M&C Saatchi | IZH | Nov 26, 2024 | 2.24 | -1.75 |
M&G | 7MP | Nov 26, 2024 | 2.40 | -1.07 |
M&T Bank Corporation | MTZ | Nov 26, 2024 | 210.90 | -0.19 |
M.P. Evans Group Plc | NYP | Nov 26, 2024 | 11.40 | -0.87 |
M/I Homes, Inc. | 4MI | Nov 26, 2024 | 161.00 | +5.26 |
M1 Kliniken AG | M12 | Nov 26, 2024 | 16.30 | -0.61 |
M3, Inc. | 4YC | Nov 26, 2024 | 8.80 | +4.14 |
MAANSHAN IRON | YM9A | Nov 26, 2024 | 0.13 | -1.52 |
Maat Pharma S.A. | 4RD | Nov 26, 2024 | 7.46 | +1.36 |
Mabion S.A. | 272 | Nov 26, 2024 | 2.76 | +1.85 |
Mabuchi Motor Co. Ltd. | V94 | Nov 26, 2024 | 13.40 | 0.00 |
Macarthur Minerals Ltd | MMLA | Nov 26, 2024 | 0.03 | -10.17 |
Macerich Company (The) | M6G | Nov 26, 2024 | 19.41 | +4.63 |
MacFarlane Group plc | 5K6 | Nov 26, 2024 | 1.22 | -2.40 |
Mack-Cali Realty Corporation | WY4 | Nov 26, 2024 | 17.30 | -0.57 |
MACOM Technology Solutions Holdings, Inc. | 1MA | Nov 26, 2024 | 127.00 | -0.78 |
MACQUARIE GROUP ADR 1 | 4M42 | Nov 26, 2024 | 137.00 | -0.72 |
Macquarie Group Ltd Ordinary shares (Australia) | 4M4 | Nov 26, 2024 | 141.72 | -0.42 |
MacroGenics, Inc. | M55 | Nov 26, 2024 | 3.10 | +1.31 |
Macromill, Inc. | MA5 | Nov 26, 2024 | 7.30 | +0.69 |
Macy`s Inc | FDO | Nov 26, 2024 | 15.14 | +1.83 |
Made Tech Group Plc | 5UH | Nov 26, 2024 | 0.26 | +0.78 |
MADISON METALS INC. | 4EF0 | Nov 26, 2024 | 0.13 | +1.60 |
Madison Square Garden Sports Corp. Class A | MS8 | Nov 26, 2024 | 218.00 | -0.91 |
Madoro Metals Corp | M5Q | Nov 26, 2024 | 0.01 | 0.00 |
Madrigal Pharmaceuticals, Inc. | YDO1 | Nov 26, 2024 | 320.60 | -2.61 |
MAEDA KOSEN CO. LTD | Z7K | Nov 26, 2024 | 11.11 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.